Benzinga · Sep 3, 2026
B. Riley Securities Maintains Buy on Nakamoto, Raises Price Target to $11
B. Riley Securities analyst Fedor Shabalin maintains Nakamoto (NASDAQ:NAKA) with a Buy and raises the price target from $9 to $11.
NA
NASDAQ · NAKA
Kindly MD, Inc.
Healthcare · Medical - Equipment & Services
$7.78
Up+$0.42 (+5.40%)
Updated Sep 16, 2026, 9:34 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 163.42M
- P/E ratio
- -0.98
- Dividend yield
- 0.00%
- 52-week range
- $0.16 – $8.60
- Volume
- 202.51K
- Avg. volume
- 26.53M
Price performance
NAKA price history
1M range · 20 trading sessions · Daily adjusted prices
NAKA closed at $7.78 after 20 trading sessions, up 55.29% for the selected period.
- Last close
- $7.78
- Period change
- +55.29%
- Period low
- $5.01
- Period high
- $8.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $8.10 | $8.10 | $7.60 | $7.78 | 202.51K |
| Sep 14, 2026 | $8.07 | $8.385 | $7.84 | $8.21 | 147.21K |
| Sep 11, 2026 | $7.82 | $8.5995 | $7.82 | $8.19 | 306.8K |
| Sep 10, 2026 | $7.77 | $8.0662 | $7.56 | $7.76 | 169.57K |
| Sep 9, 2026 | $8.085 | $8.23 | $7.77 | $7.98 | 178.75K |
| Sep 8, 2026 | $8.10 | $8.29 | $7.85 | $7.95 | 187.24K |
| Sep 4, 2026 | $8.08 | $8.41 | $7.53 | $8.13 | 213.31K |
| Sep 3, 2026 | $7.91 | $8.3199 | $7.87 | $8.31 | 202.06K |
| Sep 2, 2026 | $7.07 | $7.77 | $6.99 | $7.68 | 131.5K |
| Sep 1, 2026 | $7.29 | $7.53 | $7.01 | $7.05 | 155.21K |
| Aug 31, 2026 | $7.39 | $7.59 | $7.23 | $7.49 | 192.28K |
| Aug 28, 2026 | $7.61 | $7.80 | $7.15 | $7.44 | 179.68K |
| Aug 27, 2026 | $7.05 | $7.775 | $7.05 | $7.73 | 153.39K |
| Aug 26, 2026 | $7.10 | $7.31 | $6.87 | $6.94 | 143.89K |
| Aug 25, 2026 | $7.10 | $7.39 | $7.01 | $7.16 | 126.28K |
| Aug 24, 2026 | $7.25 | $7.46 | $6.77 | $7.20 | 271.25K |
| Aug 21, 2026 | $6.64 | $7.47 | $6.60 | $7.06 | 455.42K |
| Aug 20, 2026 | $6.11 | $6.38 | $5.95 | $6.30 | 309.07K |
| Aug 19, 2026 | $5.09 | $6.10 | $5.032 | $6.06 | 617.89K |
| Aug 18, 2026 | $4.92 | $5.19 | $4.8881 | $5.01 | 53.03K |
Latest NAKA news
The latest Smart Investors Daily articles mentioning NAKA.
Stock researchCompany · Overview
NAKA research
Overview
Company profile and research snapshot.
Company profile
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $8.00
- Implied upside
- —
- Analysts
- 8
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 3, 2026 | B. Riley Securities | Buy | — |
| Jul 27, 2026 | TD Cowen | Buy | — |
| Apr 10, 2026 | TD Cowen | Buy | — |
| Apr 6, 2026 | Maxim Group | Buy | — |
| Feb 23, 2026 | B. Riley Securities | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 2, 2026
Trump's Crypto Ally Fights to Save His Company After a 99% Crash
Nakamoto crashes 99% as David Bailey pivots from Bitcoin buying to cash-generating acquisitions and stock buybacks.
Yahoo · Aug 31, 2026
Nakamoto CEO David Bailey Says Bitcoin’s Corporate Turn Isn’t A ‘Betrayal’ – Eyes Bigger Push Into M&A
David Bailey said Bitcoin’s corporate adoption is a part of its wider growth, as Nakamoto shifts toward M&A and cash-generating businesses.
Benzinga · Aug 13, 2026
Nakamoto Q2 EPS $(6.56) Misses $(0.60) Estimate, Sales $35.869M Beat $9.422M Estimate
Nakamoto (NASDAQ:NAKA) reported quarterly losses of $(6.56) per share which missed the analyst consensus estimate of $(0.60) by 993.33 percent. This is a 53.14 percent increase over losses of $(14.00) per share from the
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
